Alzheimer's drug Leqembi launched, nausea Apple Vision Pro
Good afternoon! The launch of the closely watched Alzheimer's drug Leqembi is off to a slow start. Even so, the…
Biotechnology and pharmaceuticals
AbbVie taps Robert Michael as CEO, replacing Richard González
Test tubes are seen in front of an AbbVie logo in this illustration taken on May 21, 2021. Ruvic Dice…
What Eli Lilly Investors Can Learn from the Slow Launch of a Rival Drug
Club holding company Eli Lilly hopes to win approval for its Alzheimer's treatment in the coming weeks, but investors looking…
FTC and HHS Examine Cause of Generic Drug Shortages
A variety of generic pills and capsules. Nenov | Moment | fake images The Federal Trade Commission said Wednesday that…
Higher medical costs are hitting CVS and UnitedHealth
A UnitedHealth Group health insurance card is seen in a wallet, Oct. 14, 2019. Lucy Nicholson | Reuters Good afternoon!…
Medicare Drug Price Negotiations: Judge Dismisses PhRMA Lawsuit
Activists protest prescription drug pricing in front of the U.S. Department of Health and Human Services (HHS) building on October…
Biogen (BIIB) earnings in the fourth quarter of 2023
biogen on Tuesday reported fourth-quarter revenue and profit that fell from a year ago as it booked charges related to…
Wall Street changes its mind on these healthcare stocks. Why we were always optimistic
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
Novo Nordisk and Eli Lilly address supply issues
In this photo illustration, injectable pens of the weight loss drug Wegovy from Novo Nordisk are shown in Oslo, Norway,…
CEOs of Merck, J&J and Bristol Myers Squibb face Senate hearing on drug prices
Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey about issuing subpoenas for drug company CEOs…